Objective Juvenile idiopathic arthritis (JIA) consists of a heterogeneous group of infl ammatory disorders, within which there are a number of clinical subgroups. Diagnosis and assignment to a particular subgroup can be problematical and more concise methods of subgroup classifi cation are required. This study of the synovial membrane characterises the immunohistochemical features in early untreated, newly diagnosed JIA and compares fi ndings with disease subgroup at 2 years. Methods 42 patients with newly diagnosed untreated JIA underwent synovial biopsy before the administration of steroids or disease-modifying antirheumatic drugs. Patients were classifi ed as either polyarticular, persistent oligoarticular or extended-to-be oligoarticular. The location and semiquantitative analysis of T-cell subsets, B cells, macrophages and blood vessels were determined using immunohistochemistry. Results Synovial hyperplasia varied signifi cantly between the three groups (p<0.0001). There was a signifi cant difference in the CD3 T-cell population between the three groups (p=0.004) and between the extended-to-be and persistent group (p=0.032). CD4 expression was signifi cantly higher in the poly and extended-to-be oligo groups (p=0.002), again the extended-to-be group had more CD4 T cells than the persistent group (p=0.008). B-cell infi ltrates were more marked in the polyarticular group and were signifi cantly higher in the extended-to-be group compared with the persistent group (p=0.005). Vascularisation was more pronounced in the polyarticular and extended-to-be oligoarticular groups, the extended-to-be group had signifi cantly more vascularisation than the persistent group (p=0.0002). Conclusions There are signifi cant differences in the histomorphometric features of synovial tissue between patient subgroups. Immunohistological examination of synovial membrane biopsies may provide further insight into early disease processes in JIA.
Juvenile idiopathic arthritis (JIA) is the one of the most common rheumatological childhood diseases, with a prevalence of approximately one in 1000. 1 JIA consists of a heterogeneous group of diseases defi ned as persisting for more than 6 weeks and commencing before the age of 16 years. The cause of JIA is still unknown, environmental and genetic factors do, however, seem to play a role in its pathogenesis; moreover, the heterogeneity of the disease would suggest that multiple factors have a role to play in the pathogenesis of disease. 2 Over time persistent joint infl ammation can result in chronic pain and stiffness, joint damage and disability. Generally, the prognosis for children with JIA is relatively good; however, approximately half of the patients continue to have active joint disease into adulthood. 3 The International League of Associations for Rheumatology (ILAR) criteria are the most commonly used classifi cation system in which JIA is segregated into seven clinical subgroups. 4 5 The largest subgroup, oligoarticular JIA, accounts for approximately 65% of all cases and refers to children with four or fewer joints involved within the fi rst 6 months of disease. Oligoarticular disease is defi ned as persistent when it remains confi ned to four or fewer joints throughout the course of the disease, it is more prevalent in girls, with a peak age of onset of 1-3 years. 6 In approximately 25% of patients with oligoarticular JIA the disease may spread to four or more joints after the fi rst 6 months; 7 this is defi ned as extended oligoarticular. It is not fully understood why the disease extends and it is not possible at present to predict in whom this will occur. Polyarticular JIA is defi ned as the involvement of four or more joints in the fi rst 6 months of disease; 8 it can be subdivided into rheumatoid factor (RF)-positive and RF-negative polyarticular JIA. This subgroup accounts for approximately 10-15% of all JIA cases. 9 Across the spectrum of chronic arthritis cellular infi ltrates within the synovium promote cytokine release and enhance their production during infl ammation. 10 Chronic synovial infl ammation followed by invasion of synovial tissue into adjacent cartilage and bone results in joint deformity and ultimately disability; 11 this has been well documented in adult disease; 12 however, little is known about synovial pathology in early stage untreated JIA.
Joint disease in children with JIA is characterised by a persistent infl ammatory cellular infi ltrate into the synovium. 13 Consequently, the accumulation of T cells 14 15 encourages the production of proinfl ammatory cytokines. 16 -18 This results in subsequent over-production and secretion of synovial fl uid followed by pannus formation. If persistent, synovial infl ammation may ultimately lead to articular cartilage and bone damage.
Prahalad and Glass 18 reported that the subtypes of JIA are distinct and have the potential to be aetiologically and genetically distinctive. A number of studies has been undertaken to investigate synovial histopathology in JIA. These studies included material obtained at synovectomy, and some included children with a disease duration of up to 22.2 years and who had been treated with a variety of disease-modifying antirheumatic drugs (DMARD), 19 20 which are known to infl uence the synovial membrane fi ndings. 21 -23 The early prediction of clinical outcome in children with JIA could potentially lie in the characterisation of the cellular infi ltrates present in the synovium of early untreated infl ammatory JIA. To this end our study was designed to analyse the histology of synovial tissue from children with early stage, untreated JIA in order to identify any distinguishing features between subgroups.
METHODS
Children with newly diagnosed JIA of less than 2 years duration were recruited following informed consent. Medical ethics committee approval was obtained and patient assent and parent informed consent given (10/NIR01/11). For the purpose of this study children had to have at least one knee involved that required intra-articular steroid injection. They had to be steroid naive and never treated with DMARD. Children were classifi ed according to ILAR criteria. Detailed clinical examination, biochemical and immunological data and imaging assessments were obtained. Clinical data included: joint count, degree of clinical infl ammation in the knee (scored on a scale of 0-4; 0, no infl ammation; 1, minimal; 2, mild; 3, moderate and 4, marked), degree of any fl exion deformity of the knee, patients/parents pain scores on a visual analogue scale (VAS) and physician's global disease activity score was recorded on a VAS. Children were followed for 2 years after biopsies were taken. During this period children whose disease went on to involve more than four joints (after they had the disease for a total of six or more months) were re-classifi ed as extended oligoarticular, ie, they were not extended at the time the biopsy was taken, this subgroup is referred to as 'extended-to-be' 24 from here on in. Clinical and demographic data are included in table 1 .
Tissue collection, preparation and storage
Under general anaesthetic, synovial fl uid was aspirated and synovial membrane biopsies were obtained by blind needle biopsy using ultrasound guidance as described previously. 25 Biopsies were snap frozen in liquid nitrogen and stored at −80°C. Seven μm thick frozen sections were cut and allowed to air-dry at room temperature before histological and immunohistochemical staining.
Initial microscopic analysis of biopsies
Synovial membrane sections were stained with haematoxylin and eosin using standard protocols. 26 Three biopsies were analysed per patient, with 10 high power fi elds (HPF) studied per biopsy (×200 magnifi cation) and were scored for the following parameters: 1. Evidence of general synovial hyperplasia and fi brosis were each scored on a scale of 0-10. 2. Proliferating capillaries were assessed such that one vessel per HPF was viewed as normal with a score of 0. Additional vessels were then counted and an average taken over 10 HPF. 3. Focal cell aggregates (FA) (aggregates greater than 10 cells in diameter, or those that did not involve a vessel) were scored as absent (A) or present (P). 4. Infl ammatory infi ltrates of lymphocytes (II) were scored as a percentage of the total cell population per HPF, in which 1=10% and 10=100% cells.
Immunohistochemistry
To address the issue of the number of biopsies required to obtain representative data of the cellular infi ltration into the synovial tissue, 27 the maximal number of biopsies available for each child was utilised. An average of three biopsies per patient were analysed. Per biopsy, 10 HPF were studied (×200 magnifi cation) for the presence and magnitude of positively stained cells, ie, the percentage of cells positively stained for each marker was recorded for 10 different HPF and averages were calculated. Antibodies were optimised in lymphoid tissue and isotype matched negative controls used for each immunohistochemical stain. Evaluation of stained sections was performed by two independent, blinded authors (SF and SC). Four patient samples could not be included in the study as the tissue was * Patients were classifi ed as oligoarticular at time of biopsy but were subsequently reclassifi ed as extended oligoarticular if more than four joints became involved after the fi rst 6 months of disease, ie, at biopsy they were oligoarticular, only later did they extend. † See supplementary fi gure 3 (available online only) for time at which disease extended for each patient. ‡ Given are the number of swollen joints in extended-to-be patients at the time of biopsy (before they extended). When all 10 patients in this group were reclassifi ed as extended (after an average of 18 months disease duration) the average number of swollen joints was 6.2 (range 5-10) (see supplementary fi gure 4, available online only). § No data for one patient. ¶ No data for two patients. ANA, antinuclear antibodies; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; PC, platelet count; RF, rheumatoid factor; VAS, visual analogue scale; WCC, white cell count.
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A semiquantitative fi ve-point scale was developed to represent the percentage of cells that were positively stained: 0 represented no cells; 1, 1-24%; 2, 25-49%; 3, 50-74% and 4, 75-100% of cells expressing the markers. This scale was used for all cell markers, unless otherwise stated. As some histological markers are more abundant than others in synovial tissue, we adjusted the scoring system appropriately for each individual marker based on examining a representative number of biopsies for each marker, thus the sensitivity of the scoring system was different for some markers as described for CD20 expression (below).
CD20 expression appeared in a more focal arrangement than CD3, CD4, CD8 and CD68, and so scoring per HPF would not have given a true representation of its expression. Instead, CD20 expression was given an overall score based on its expression in an entire piece of synovial tissue, all tissues analysed were approximately the same size. It was scored as follows: score 0, no CD20 expression; score 1, 1 FA of CD20 cells; score 2, 2 FA of CD20 cells; score 3, 3 FA of CD20 cells; score 4, 4 or more FA of CD20 cells.
The thickness of the lining layer (LL) was assessed on CD68 stained sections based on the number of thick cells that were positively stained, the mean was calculated for 10 HPF. Vessel markers were counted starting at the top left hand corner of the specimen, and 10 HPF were selected as previously described.
Statistical analysis
All statistical analysis was performed with the Analyse-it addin statistics software package in Excel. Clinical data were not normally distributed therefore differences between the three subgroups were analysed using the Kruskal-Wallis one-way analysis of variance. Pearson correlation tests were used to evaluate tissue scores between the two blinded observers and correlations between particular histological features. The two observers were blinded to the clinical and diagnosis data. Scores awarded by the two observers SF and SC were highly correlated (r=0.93, p<0.0001).
RESULTS

Patient demographics and clinical features
There were 33 females and nine males included in the study. The clinical and laboratory fi ndings are shown in table 1 .
General laboratory characteristics of JIA patients
By defi nition of the study inclusion criteria, all had at least one knee involved in disease. There was no signifi cant difference in the mean infl ammation/knee swelling score of the biopsied knees between subgroups: polyarticular (mean 3.3), persistent (mean 3), extended-to-be (mean 3.3) (see supplementary fi gure S1, available online only). There was no signifi cant correlation between infl ammation/knee swelling score and any of the immunohistological features. Within the polyarticular subgroup there was a tendency towards a correlation between CD3/CD4 expression (r=0.45 and 0.69, respectively) and infl ammation/knee swelling score; however, the correlation did not reach statistical signifi cance. There were signifi cant differences in C-reactive protein levels between the polyarticular (mean 49.81) and extended-to-be oligoarticular subgroups (mean 8.34; p=0.0071) and between the polyarticular and persistent oligoarticular JIA subgroups (mean 9.23; p=0.0036). The erythrocyte sedimentation rate was signifi cantly higher in the polyarticular (mean 59.33) compared with the persistent oligoarticular subgroup (mean 20.75; p=0.006). VAS pain scores (parent) were signifi cantly higher in the polyarticular (mean 6.94) compared with the persistent oligoarticular subgroup (mean 4.34; p=0.031), and when assessed by a physician the VAS pain score was also significantly higher in the polyarticular (mean 4.46) compared with the persistent oligoarticular subgroup (mean 1.84; p=0.0005). There was a signifi cant difference in the white cell count between the persistent (mean 9.54) and extended-to-be oligoarticular groups (mean 12.68; p=0.055) ( table 2 ).
Synovial hyperplasia and infl ammatory infi ltrates
The degree of synovial hyperplasia was assessed using standard methods on haematoxylin and eosin stained sections and was scored on a scale of 1-10. The degree of synovial hyperplasia and infl ammation varied according to the disease subgroup: polyarticular subgroup (mean 9.45; range 8.5-10), persistent oligoarticular (mean 6.4; range 2-9), extended-to-be oligoarticular (mean 8.35; range 5-10), and there was a signifi cant difference in the degree of synovial hyperplasia between the three subgroups (p<0.0001) ( fi gure 1 and table 2 ). Fibrosis was scored on a scale of 1-10; it did not vary signifi cantly between the three subgroups ( table 2 ).
Infl ammatory infi ltrates
Infl ammatory infi ltrates of lymphocytes were scored on a scale of 1-10. There was a signifi cant variable degree of infl ammation between the three groups (p=0.0054). When the polyarticular (mean 8.8; range 8.5-10) was compared with the persistent oligoarticular group (mean 6.4; range 1.7-9) there was a significant difference between the two (p=0.0025). B-cell and T-cell focal aggregates were observed in 60% of polyarticular patients, 73% of extended-to-be patients and 48% of persistent patients ( table 2 ) . Mean score is presented (+SEM). II (Infl ammatory infi ltrates) were scored on a scale of 0-10 on haematoxylin and eosin stained sections. SH was scored on a scale of 0-10. PI scored on the number of vessels/HPF that were associated with perivascular infi ltrates. Fibrosis was scored on a scale of 0-10, where a score of zero represented no fi brosis and 10 meant that 100% of the tissue was fi brotic. FA were scored as absent or present, shown is the percentage of samples in each group that were positive for the presence of focal aggregates. FA, focal cell aggregate; HPF, high power fi eld; JIA, juvenile idiopathic arthritis; PI, perivascular infi ltrates; RF, rheumatoid factor; SH, synovial hyperplasia.
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There was a signifi cant difference in CD3 T-cell expression (p=0.004) between the three subgroups, with polyarticular (mean 3.1; range 1.71-4) and extended-to-be oligoarticular (mean 2.88; range 2-3.75) groups having higher CD3 scores. When the extended-to-be oligoarticular group was compared with the persistent oligoarticular group (mean 2.04; range 0.5-3.75) there was a signifi cant difference in CD3 T-cell expression (p=0.032) ( fi gure 2A and table 3 ). Similarly for CD4 there was also a signifi cant difference in expression between the three subgroups (p=0.002), and again there was a signifi cant difference in CD4 expression between the persistent (mean 1.35; range 0.3-2.3) and extended-to-be oligoarticular group (mean 2.24; range 1.2-3.63) (p=0.008) ( fi gure 2 and table 3 ).
CD8 expression was not signifi cantly different between the subgroups.
B-cell expression
Distinct clusters of CD20 B cells were observed in all three subgroups. In general, B cells demonstrated a focal appearance rather than a diffuse expression pattern, with distinct perivascular groups of CD20 cells found surrounding vessels in some biopsies ( fi gure 3 ). There was a signifi cant difference in CD20 expression between the three groups (p=0.004), and when the polyarticular group (mean 2.55; range 1-4) was compared with the persistent oligoarticular (mean 0.93; range 0-3) there was a signifi cant difference in CD20 expression (p=0.0014) and there was also a signifi cant difference in expression between the persistent and extended-to-be oligoarticular (mean 1.95; range 0.5-4) groups (p=0.005) ( table 3 ).
Macrophage expression
There were marked macrophage populations in the lining layer and the sublining layer in all three subgroups, with all three displaying moderate/strong CD68 expression in the lining layer, with less pronounced but still marked expression in the sublining layer ( table 3 ) .
As the number of cells in the synovial lining layer are known to increase with synovitis we measured the average cell depth of this layer; no signifi cant difference was found between subgroups ( table 3 ) .
Angiogenesis
Infl amed synovial tissue for all patients in the study displayed an increased number of blood vessels beyond the normal threshold value of one vessel/HPF. Factor VIII + was used as a vessel marker, the degree of vascularisation varied signifi cantly with disease subgroup (p=0.01), with higher numbers of factor VIII + vessels in extended-to-be (mean 25.2 vessels/HPF; range 18-32 vessels/ HPF) and polyarticular (mean 20.5 vessels/HPF; range 11.1-31.8 vessels/HPF) groups. There was also a signifi cant difference in factor VIII + expression between the persistent (mean 12.2 vessels/HPF; range 1-25.23 vessels/HPF) and extended-to-be subgroups (p=0.0002) ( table 3 and fi gure 4 ). We also examined the expression of αVβ3, which is expressed on endothelial cells during the early stages of angiogenesis; its expression in both the persistent and extended oligoarticular groups was quite low (mean 3.7 vessels/HPF) but we found a signifi cant difference in expression between the three subgroups, with the polyarticular group showing the highest expression (mean 10.5 vessels/HPF; p=0.006) ( fi gure 4 ).
DISCUSSION
The results presented in this study demonstrate differences in the immunohistological characteristics of polyarticular, persistent oligoarticular and extended-to-be oligoarticular synovial biopsy specimens taken at an early disease stage (mean disease duration 5.33 months-see supplementary fi gure 2, available online only) and before the initiation of any steroid or DMARD. Within the polyarticular group only two patients were RF positive. We have presented results in the tables for both the RF-positive and negative groups separately; however, due to these small sample numbers we analysed the polyarticular group overall as a whole. Statistically signifi cant higher scores for infi ltration by CD3, CD4, CD20 cells were observed between the three groups. There was also signifi cantly more angiogenesis in the extendedto-be oligoarticular and polyarticular groups. Synovial tissue from the polyarticular and extended-to-be oligoarticular groups also had higher scores for synovial hyperplasia; there was also a tendency for more focal aggregates of lymphocytes to be present in the polyarticular and extended-to-be oligoarticular tissue. We found no signifi cant correlation between disease duration and any of the immunohistochemical parameters. We postulate that highly infl ammed synovial tissue with marked hyperplasia scores, high CD3/CD4 expression and a high angiogenesis score in children who initially present with oligoarticular JIA could be an early indication that disease may spread to other joints.
The formation of new blood vessels from an early stage in disease is a critical process in the perpetuation of the infl ammatory response in the synovium of patients with rheumatoid arthritis (RA) and JIA. 28 This then facilitates the active infi ltration of the synovial membrane into cartilage, ultimately destroying the cartilage and leading to bone deformity. 29 We found significantly more angiogenesis in the extended-to-be and polyarticular subgroups; these initial results would suggest that higher angiogenesis scores may imply a more severe disease phenotype (polyarticular) and/or the possibility of disease extension. To our knowledge this is the fi rst study to demonstrate this relationship; it would be interesting in future studies to examine further the relationship between angiogenesis and disease extension. Ultimately, more patients would be required to validate these initial results.
We also investigated the expression of αVβ3, which is upregulated on endothelial cells during angiogenesis. 30 We found αVβ3 localised around small vessels with much less intensity than factor VIII + . There was signifi cantly more αVβ3 expression in the polyarticular subgroup than the other two subgroups. αVβ3 is only found on early undifferentiated vessels and is lost as vessels mature. 31 Our results imply that not only are there increased numbers of mature vessels in polyarticular tissue, but the process of angiogenesis is ongoing within this subgroup, as demonstrated by the presence of an early vessel marker. Of interest is the fact that even though the extended-to-be oligoarticular group had a higher mean score for factor VIII expression, its score for αVβ3 was minimal as in the persistent subgroup. Interestingly
Barnes et al 32 found specifi c genes related to angiogenesis were upregulated in polyarticular synovial fl uid and angiostatic factors were increased in oligoarticular samples. They suggest this may tip the balance towards greater angiogenic activity in polyarticular disease when compared with oligoarticular disease, and this may have a role to play in the more severe phenotype of polyarticular JIA.
Figure 4
The highly specifi c endothelial cell marker von Willebrand factor (factor VIII) was used to demonstrate that infl amed juvenile idiopathic arthritis (JIA) synovial tissue contained an increased number of blood vessels. There was signifi cantly higher factor VIII + expression in the polyarticular (A) and extended-to-be oligoarticular (C) subgroups when compared with the persistent oligoarticular (B) subgroup. Representative sections of synovial membrane are shown for each subgroup. Sections were counterstained with haematoxylin. The bar chart illustrates the mean number of factor VIII + vessels per high power fi eld (HPF) for the three JIA subgroups (+SEM). αVβ3 expression on serial sections of the same biopsy from the same patient. This tissue is from a patient with polyarticular JIA, there are many mature vessels present as shown by the presence of factor VIII (D), it is evident that angiogenesis is ongoing as there are also many early vessels as shown by the expression of αVβ3 (E). Arrows indicate vessels that have stained positive for αVβ3 and not for factor VIII. Both sections have been counterstained with haematoxylin. The bar chart illustrates the mean number of αVβ3 + vessels per HPF for the three JIA subgroups: polyarticular (P), persistent oligoarticular (O) and extended-to-be oligoarticular (EO) (+SEM).
A number of studies has previously been undertaken to characterise synovial T-cell infi ltrates in patients with RA and JIA; however, these studies were all undertaken in children with established treated disease, when medications known to alter the synovial microenvironment had been used. Murray et al 33 found higher levels of CD4 and CD8 T cells in oligoarticular childhood-onset chronic arthritis when compared with polyarticular disease; however, the study had preferentially selected samples that displayed signifi cant infl ammation and high CD3 and CD68 expression, thus introducing a selection bias of the patient group for disease activity. Gattorno et al 19 analysed synovial tissue from patients with a an average disease duration of over 3 years who had all been treated with methotrexate. In a later study by Kruithof et al , 34 in which the authors concluded that synovial histology did not correspond with any particular JIA subgroup, these patients too had been receiving treatment in the form of DMARD and/or corticosteroids before biopsy; these treatments are known to alter the synovial microenvironment signifi cantly. 21 -23 In another study by Gattorno et al 35 the synovial tissue from six patients with a mean age at the time of biopsy of 15.8 years was used. There was no mention of disease duration in these patients, and it is also unclear if the patients had been receiving any DMARD before biopsy.
Gregorio et al 20 investigated the pattern of lymphoid organisation in JIA; however, the mean disease duration was 6.7 years and the majority of patients had all been treated with DMARD, some with anti-tumour necrosis factor, some with methotrexate and some with steroids. In another study by Nistala et al , 36 the children were all receiving either methotrexate or corticosteroids before sample collection. Those studies are distinct from the current study, which focused specifi cally on early, untreated disease (mean disease duration at the time of biopsy was 5.33 months) as none of the patients in our study had received any DMARD before biopsy.
In a more recent study by Hunter et al 24 synovial fl uid samples from treatment-naive JIA patients were studied. The authors found the CD4:CD8 ratio in synovial fl uid of children with extended JIA was signifi cantly lower than those with persistent disease. In our study we found an increased CD4:CD8 T-cell ratio in the synovial membrane of children with extended-tobe disease. The study by Hunter et al 24 was carried out using cells within synovial fl uid, which could account for the discrepancy between the fi ndings of our study. Furthermore, a previous study by Ravlic-Gulan et al 37 found that RA patients had a decreased CD4:CD8 ratio in synovial fl uid but an increased ratio of CD4:CD8 in the synovial membrane when compared with the ratio in peripheral blood, possibly implying that there are differences in the local immunological events occurring in synovial membrane and synovial fl uid. It would be interesting to investigate further this reciprocal relationship. Could it be possible that the higher CD4:CD8 ratio in the synovial fl uid is as a result of traffi cking out of the infl amed tissue?
Of interest within the polyarticular JIA subgroup is one patient who had below average scores for CD3/CD4/CD8. They initially presented with only 1 month of symptoms and were classifi ed as oligoarticular JIA. After 3 months of the initial diagnosis, however, this patient was re-classifi ed as polyarticular. It would be interesting to follow up this patient and investigate the synovial histopathology at the end of the 2-year study to determine if pathology had become more pronounced.
As the diagnosis of JIA is essentially down to clinical assessment and no laboratory test can be conclusive for JIA diagnosis, there are undoubtedly some fl aws within the classifi cation system. Most often, joint count is used as an initial diagnostic criterion to determine subgroup classifi cation. Inherently there will be some error as joint counts may differ between observers and it also depends on parental and child recall; however, ILAR is currently the accepted international classifi cation and thus the one we have to work with. There is without doubt a lack of correlation between immunochemistry, genetics and histopathology and specifi c JIA subgroups. The current ILAR classifi cation system is often regarded as an ongoing work in progress, which will be amended as future studies provide more insight into JIA classifi cation. 38 At present, there is no defi nitive way to predict whether disease will spread to more than four joints in a child who initially presents with oligoarticular JIA. It is therefore imperative to try and devise new methods that could help predict disease extension, so that more effective treatment could be implemented at an earlier stage in the disease process. Indeed, what we have shown is that there are already differences at the level of synovial histology before extension occurs; these results could be the basis for further research to help determine specifi c criteria in order to stratify JIA patients better. We postulate that the timely prediction of clinical outcome could be facilitated by the characterisation of cellular infi ltrates present in early untreated infl ammatory JIA.
